IDKmonitor® Golimumab Drug Level ELISA

The IDKmonitor® Golimumab Drug Level ELISA is intended for the quantitative determination of free golimumab (therapeutic antibody against TNF-alpha, e.g. SIMPONI®) in EDTA plasma and serum.

For research use only. Not for use in diagnostic procedures.

For Laboratory Professional Use Only.

If you’re in Canada, we offer a Health Canada Licensed version of this kit: K9656

Manufactured by Immundiagnostik AG.

Also available:

• Golimumab Free ADA ELISA: KR9649

Test Principle of the IDKmonitor® Golimumab Drug Level ELISA

This ELISA is designed to determine the quantity of free golimumab (therapeutic antibody against TNFα) in EDTA plasma or serum samples.

In the first incubation step, free golimumab from the sample is bound to the specific monoclonal anti-golimumab antibody coated on the plate. A washing step is carried out to remove all unbound substances. In a further incubation step, a peroxidase-labeled antibody is added. Tetramethylbenzidine (TMB) is used as a substrate for peroxidase. Finally, an acidic stop solution is added to terminate the reaction.

The color changes from blue to yellow. The intensity of the yellow color is directly proportional to the concentration of free golimumab in the sample. Using the values obtained from the standard, a dose-response curve of the absorbance unit (optical density, OD at 450 nm) vs. concentration is generated. The concentrations of free golimumab in the samples are determined directly from this curve.